Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
EquipmentShare.com enters the week of October 10 with a striking split: the stock has shed 18.5% in five sessions to $15.09, yet its own founders keep buying and analyst targets remain more than double the current price.
The most readable signal on the stock right now is in options. The put/call ratio jumped to 0.38 on October 9, more than three and a half standard deviations above its 20-day average of 0.18. That is the most defensive options posture the market has struck in weeks. For a ticker where calls typically swamp puts by a wide margin, a PCR reading this elevated in a single session suggests traders scrambled for downside protection as the weekly slide accelerated. The ORTEX short score has eased slightly from a recent high of 70.2 on September 28 to 61.7, meaning some of the short-side pressure is unwinding even as the stock falls, a divergence worth watching. Borrow availability is loose at 288%, roughly three shares available for every one already lent out, so there is no squeeze pressure in the lending market and no mechanical friction slowing the selloff.
The Street broadly holds a constructive view, but has been cutting targets steadily. Truist Securities reiterated Buy on October 5 and lowered its target from $35 to $31. Earlier, UBS trimmed to $22 (Neutral) and Wells Fargo cut from $32 to $25 (Overweight). The mean analyst target is $32.30 against a stock trading at $15, implying more than 100% upside on paper. The bull case rests on a genuine growth story: Q2 2026 rental revenue rose 39.5% year-on-year, core EBITDA expanded 41%, and 430 locations with $9.9 billion of OEC back the scale argument. Bears point to cyclical construction exposure, a heavily debt-funded growth model, and intense pressure from United Rentals, Sunbelt Rentals, and Herc Rentals. The EV/EBITDA multiple has compressed to 3.8x over the past 30 days, down roughly 0.3 turns, as the price decline has outrun any earnings revision. The price-to-book ratio has similarly pulled back to 2.6x.
The founder buying is the clearest expression of internal confidence. CEO Jabbok Schlacks made open-market purchases on September 1, 2, 14, and 15, paying between $17.03 and $18.00 per share for a combined 65,000 shares across those dates, each transaction filed without a pre-arranged 10b5-1 plan, so fully discretionary. Co-founder and President William Schlacks added 10,000 shares at $17.79 on September 2, also without a plan. The purchases were made at prices already well above where the stock trades today. The 90-day net insider position is negative at roughly minus 2.1 million shares, reflecting earlier disposals, but the recent cluster of open-market buys from both co-founders at prices that have since been undercut stands as the most direct signal of conviction in the data. Jabbok Schlacks also carries a Schedule 13D filing on the register, confirming activist-level engagement rather than passive ownership. As always with 13D/G disclosures, the percentage figures are as last reported around the 5% threshold and may not reflect subsequent changes.
Institutional ownership is concentrated. Romulus Capital holds 21% of shares outstanding, unchanged as of August 18. Wellington Management added 3.2 million shares through July, and T. Rowe Price added 2.8 million shares through September 30. Those are material additions from two large active managers, pointing in the same direction as the founders' purchases.
ORTEX puts the probability of EQPT joining the Russell 2000 at 76% at the December 2026 Semi-Annual Review, with a rank date of October 30 and announcement date of November 13. The estimated tracker buying flow is $211 million, equivalent to about 4.3 days of normal volume. The rank date falls three weeks away. In past comparable additions, the median stock moved minus 4% from announcement to effective date, and just 55% moved the expected direction, so the mechanical flow has historically been far from a reliable tailwind. The price that decides eligibility is $0.57, well below current levels, so the qualification itself is not in question.
The next earnings print is scheduled for November 13, the same date as the Russell announcement. That collision of the index decision and the company's own quarterly numbers makes the five weeks ahead unusually data-dense for a stock already trading at a fraction of where analysts set their targets.
See the live data behind this article on ORTEX.
Open EQPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
